Key information
Delivery type
Hybrid – Face to face or online
Delivery style
- Face-to-face (in-person teaching sessions at a specific venue)
- Online (live)
Duration
One day
Experience level
All
Cost
- Onsite: £110
- Virtual: £110
- Low- and Middle-Income Countries (LMIC): £50
- Student: £70
- Offer 5 for 4 (onsite and virtual): £84
- Pharma and industry: £200
What to expect
Haematological malignancies are among the most complex and rapidly evolving areas in oncology, with advances in diagnostics, targeted therapies and cellular treatments continuing to reshape how patients are diagnosed, treated and supported. As the breadth of haematology care grows, so does the need for healthcare professionals across all disciplines to build and refresh their confidence in understanding the diseases, the treatments and the complications that can arise.
This hybrid study day provides an accessible and practical introduction to haematology care, equipping healthcare professionals across all disciplines with the foundational knowledge needed to better understand, support and care for patients with haematological conditions.
Delegates will explore the principles of haematopoiesis, diagnostic pathways, treatment approaches and supportive care considerations through clinically focused teaching and multidisciplinary discussion. The programme will also address emerging therapies, blood product management and recognition of acute deterioration in haematology patients.
Learning outcomes
- Explain the principles of haematopoiesis and apply foundational diagnostic principles to support understanding of haematological malignancies
- Describe the pathways and tests used to diagnose haematological malignancies, including the role of the Clinical Nurse Specialist
- Identify the key features, treatment approaches and care considerations for Lymphoma, Leukaemia, Myeloma and CLL
- Describe the principles of stem cell transplantation, CAR-T therapy and bispecific therapies, and their role in haematology care
- Apply safe practice principles in relation to blood transfusion, blood products and major haemorrhage protocols
- Recognise the signs of acute deterioration in haematology patients and respond appropriately to support timely and effective management
Why choose this programme
This study day provides a clinically relevant and accessible introduction to modern haematology care, combining current evidence, practical learning and multidisciplinary perspectives to support safer and more effective patient care across a range of healthcare settings.
Who is it for?
Suitable for all healthcare professionals who encounter or support patients with haematological conditions, whether new to haematology or looking to refresh and consolidate existing knowledge. Relevant across all experience levels and care settings.
How to book/learn more
You can book this course on Eventbrite.
Not ready to book? Find out more
What's new?
The Christie Institute news-
Read more about Coming soon! Master’s in Advancing Future Cancer CareComing soon! Master’s in Advancing Future Cancer Care
Our Masters in Advancing Future Cancer Care is a new postgraduate programme for healthcare professionals who want to deepen their specialist knowledge, strengthen their practice and help shape the future of cancer care.
-
Read more about It starts with listeningIt starts with listening
Across the NHS, discussions about accessibility, inclusion, co-production and health inequity are much more fluent and occur in ways that perhaps would not have been possible even a decade ago.
-
Read more about The Christie Institute for Cancer Education recognised by European cancer networkThe Christie Institute for Cancer Education recognised by European cancer network
The Christie Institute for Cancer Education has been recognised by the Organisation of European Cancer Institutes (OECI) for its international, inclusive and integrated approach to cancer education.